These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27843019)

  • 1. The Trypanosoma cruzi Surface, a Nanoscale Patchwork Quilt.
    Mucci J; Lantos AB; Buscaglia CA; Leguizamón MS; Campetella O
    Trends Parasitol; 2017 Feb; 33(2):102-112. PubMed ID: 27843019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theft and Reception of Host Cell's Sialic Acid: Dynamics of
    da Fonseca LM; da Costa KM; Chaves VS; Freire-de-Lima CG; Morrot A; Mendonça-Previato L; Previato JO; Freire-de-Lima L
    Front Immunol; 2019; 10():164. PubMed ID: 30787935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialic Acid Glycobiology Unveils Trypanosoma cruzi Trypomastigote Membrane Physiology.
    Lantos AB; Carlevaro G; Araoz B; Ruiz Diaz P; Camara Mde L; Buscaglia CA; Bossi M; Yu H; Chen X; Bertozzi CR; Mucci J; Campetella O
    PLoS Pathog; 2016 Apr; 12(4):e1005559. PubMed ID: 27058585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid acceptors of different stages of Trypanosoma cruzi are mucin-like glycoproteins linked to the parasite membrane by GPI anchors.
    Acosta A; Schenkman RP; Schenkman S
    Braz J Med Biol Res; 1994 Feb; 27(2):439-42. PubMed ID: 8081262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi surface mucins: host-dependent coat diversity.
    Buscaglia CA; Campo VA; Frasch AC; Di Noia JM
    Nat Rev Microbiol; 2006 Mar; 4(3):229-36. PubMed ID: 16489349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
    Giorgi ME; de Lederkremer RM
    Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialoglycoconjugates in Trypanosoma cruzi-host cell interaction: possible biological models--a review [corrected].
    Vermelho AB; Meirelles MN
    Mem Inst Oswaldo Cruz; 1994; 89(1):69-79. PubMed ID: 7823823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living dangerously: how Trypanosoma cruzi uses lysosomes to get inside host cells, and then escapes into the cytoplasm.
    Andrews NW
    Biol Res; 1993; 26(1-2):65-7. PubMed ID: 7670547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanisms of Trypanosoma cruzi invasion of mammalian cells.
    Burleigh BA; Andrews NW
    Annu Rev Microbiol; 1995; 49():175-200. PubMed ID: 8561458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of trypomastigote trans-sialidase in metacyclic forms of Trypanosoma cruzi increases parasite escape from its parasitophorous vacuole.
    Rubin-de-Celis SS; Uemura H; Yoshida N; Schenkman S
    Cell Microbiol; 2006 Dec; 8(12):1888-98. PubMed ID: 16824037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages.
    Camargo MM; Andrade AC; Almeida IC; Travassos LR; Gazzinelli RT
    J Immunol; 1997 Dec; 159(12):6131-9. PubMed ID: 9550414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From lysosomes into the cytosol: the intracellular pathway of Trypanosoma cruzi.
    Andrews NW
    Braz J Med Biol Res; 1994 Feb; 27(2):471-5. PubMed ID: 8081267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional properties of Trypanosoma trans-sialidase.
    Schenkman S; Eichinger D; Pereira ME; Nussenzweig V
    Annu Rev Microbiol; 1994; 48():499-523. PubMed ID: 7826016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity.
    Yoshida N
    Parasitol Int; 2008 Jun; 57(2):105-9. PubMed ID: 18234547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
    Miller BR; Roitberg AE
    Future Med Chem; 2013 Oct; 5(15):1889-900. PubMed ID: 24144418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Infectivity and Evasion Derived from Microvesicles Cargo Produced by
    Borges BC; Uehara IA; Dias LO; Brígido PC; da Silva CV; Silva MJ
    Front Cell Infect Microbiol; 2016; 6():161. PubMed ID: 27921011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of the diversity among members of the Trypanosoma cruzi trans-sialidase family analyzed with camelids single-domain antibodies.
    Ratier L; Urrutia M; Paris G; Zarebski L; Frasch AC; Goldbaum FA
    PLoS One; 2008; 3(10):e3524. PubMed ID: 18949046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoleamine 2,3-dioxigenase (IDO) is critical for host resistance against Trypanosoma cruzi.
    Knubel CP; Martínez FF; Fretes RE; Díaz Lujan C; Theumer MG; Cervi L; Motrán CC
    FASEB J; 2010 Aug; 24(8):2689-701. PubMed ID: 20233946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diversity of the Trypanosoma cruzi TcSMUG family of mucin genes and proteins.
    Urban I; Santurio LB; Chidichimo A; Yu H; Chen X; Mucci J; Agüero F; Buscaglia CA
    Biochem J; 2011 Sep; 438(2):303-13. PubMed ID: 21651499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive glycoprofiling of the epimastigote and trypomastigote stages of Trypanosoma cruzi.
    Alves MJ; Kawahara R; Viner R; Colli W; Mattos EC; Thaysen-Andersen M; Larsen MR; Palmisano G
    J Proteomics; 2017 Jan; 151():182-192. PubMed ID: 27318177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.